+175.9%
SLV vs THC
+1,325.8%
-1,149.9%
-57.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.7% | +2.0% | +0.7% | +2.6% |
| 7D | +5.6% | +7.5% | -1.8% | +5.2% |
| 30D | -12.1% | +9.6% | -21.7% | -12.7% |
| 3M | -16.3% | +10.3% | -26.5% | -16.8% |
| 6M | -34.1% | +51.8% | -85.9% | -36.0% |
| YTD | -25.3% | +45.4% | -70.7% | -27.4% |
| 1Y | +9.6% | +40.8% | -31.2% | +6.7% |
| 3Y | +132.7% | +448.8% | -316.1% | +107.4% |
| 5Y | +113.7% | +263.4% | -149.7% | +92.2% |
| 10Y | +175.9% | +1,800.1% | -1,624.2% | +135.3% |
| All | +175.9% | +1,325.8% | -1,149.9% | +135.3% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling